M. A. von Wichmann

591 total citations
10 papers, 103 citations indexed

About

M. A. von Wichmann is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, M. A. von Wichmann has authored 10 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Hepatology. Recurrent topics in M. A. von Wichmann's work include Hepatitis C virus research (3 papers), Liver Disease and Transplantation (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). M. A. von Wichmann is often cited by papers focused on Hepatitis C virus research (3 papers), Liver Disease and Transplantation (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). M. A. von Wichmann collaborates with scholars based in Spain, Chile and Germany. M. A. von Wichmann's co-authors include Juan A. Pineda, Enrique Ortega, Antonio Rivero, Juan Macı́as, Javier García‐Samaniego, Ana Moreno, Raúl Gilarranz Luengo, Samuel Bernal, Gustavo Cilla and Á. Castro and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Molecular Sciences and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. A. von Wichmann

9 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. A. von Wichmann Spain 6 71 55 27 16 10 10 103
Raul Davaro United States 6 66 0.9× 22 0.4× 39 1.4× 9 0.6× 4 0.4× 8 93
H. Lafeuille France 6 84 1.2× 69 1.3× 20 0.7× 9 0.6× 4 0.4× 10 117
Sunčanica Ljubin Sternak Croatia 5 37 0.5× 27 0.5× 68 2.5× 13 0.8× 11 1.1× 12 105
Luis Escosa Spain 7 41 0.6× 10 0.2× 26 1.0× 6 0.4× 5 0.5× 14 92
F.P. Antonucci Italy 4 36 0.5× 32 0.6× 37 1.4× 11 0.7× 10 77
Louise Downs United Kingdom 7 79 1.1× 53 1.0× 24 0.9× 6 0.4× 3 0.3× 16 116
Rosa Daza Spain 4 100 1.4× 7 0.1× 17 0.6× 6 0.4× 12 1.2× 7 155
Rozenn Esvan Italy 6 44 0.6× 58 1.1× 46 1.7× 2 0.1× 14 1.4× 16 110
Tânia Reuter Brazil 7 58 0.8× 35 0.6× 41 1.5× 2 0.1× 8 0.8× 19 94

Countries citing papers authored by M. A. von Wichmann

Since Specialization
Citations

This map shows the geographic impact of M. A. von Wichmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. von Wichmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. von Wichmann more than expected).

Fields of papers citing papers by M. A. von Wichmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. von Wichmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. von Wichmann. The network helps show where M. A. von Wichmann may publish in the future.

Co-authorship network of co-authors of M. A. von Wichmann

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. von Wichmann. A scholar is included among the top collaborators of M. A. von Wichmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. von Wichmann. M. A. von Wichmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wichmann, M. A. von, Cécile L. Maire, Katharina Kolbe, et al.. (2023). Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs. International Journal of Molecular Sciences. 24(14). 11399–11399. 5 indexed citations
2.
Wichmann, M. A. von, et al.. (2015). Rural Inflammatory Bowel Disease Care in Australia: Disease Outcomes and Perceived Barriers to Optimal Care. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 2(2). 3 indexed citations
3.
Piñeiro, Luis, Samuel Bernal, Ana Bordes Benítez, et al.. (2014). Minimum spread of the new Swedish variant of Chlamydia trachomatis and distribution of C. trachomatis ompA genotypes in three geographically distant areas of Spain, 2011–2012. Infection. 42(5). 905–912. 16 indexed citations
4.
Macı́as, Juan, Manuel Márquez, Francisco Téllez, et al.. (2013). Risk of Liver Decompensation Among HIV/Hepatitis C Virus-Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy. Clinical Infectious Diseases. 57(10). 1401–1408. 20 indexed citations
5.
Macı́as, Juan, Karin Neukam, Joaquín Portilla, et al.. (2011). Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C. Journal of Antimicrobial Chemotherapy. 66(6). 1346–1350. 13 indexed citations
6.
Moreno, Santiago, Javier García‐Samaniego, Ana Moreno, et al.. (2009). Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co‐infection. Journal of Viral Hepatitis. 16(4). 249–258. 24 indexed citations
7.
Arriola-Guevara, Enrique, et al.. (2004). Guía de actuación ante Staphylococcus aureus resistente a meticilina (SARM) en centros gerontológicos, sociosanitarios y unidades de media-larga estancia. Revista Española de Geriatría y Gerontología. 39(5). 329–341. 7 indexed citations
8.
Arrizabalaga, Jon, et al.. (1998). [The usefulness of the desensitization to rifampin in the treatment of mycobacterial disease in patients with AIDS].. PubMed. 111(3). 103–4. 5 indexed citations
9.
Wichmann, M. A. von, et al.. (1998). [Pulmonary cavitation lesions in patients infected with the human immunodeficiency virus: an analysis of a series of 78 cases].. PubMed. 111(19). 725–30. 9 indexed citations
10.
Iribarren, José Antonio, et al.. (1994). Tratamiento y quimioprofilaxis de la tuberculosis en 1993. 18(1). 1–17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026